期刊文献+

重组人成纤维细胞生长因子-21的表达及纯化工艺的优化 被引量:2

Optimization of Procedure for Expression and Purification of Recombinant Human Fibroblast Growth Factor-21
原文传递
导出
摘要 目的优化重组人成纤维细胞生长因子-21(SUMO-rhFGF-21)融合表达工程菌的表达条件及目的蛋白纯化工艺。方法对工程菌的诱导温度、时间及诱导剂浓度进行优化,并进行罐发酵,对菌体裂解液进行离子交换层析、Ni离子亲和层析及分子筛层析等。纯化产物经SDS-PAGE和HPLC鉴定纯度。结果在诱导温度为37℃,诱导时间为4h,IPTG浓度为0.5mmol/L时,目的蛋白的表达量最高,达20.5%;罐发酵收菌量可达66g/L,目的蛋白的表达量达20.2%;纯化后的rhFGF-21纯度达96%以上。结论优化了rhFGF-21的表达条件及纯化工艺,为rhFGF-21用于新药开发奠定了基础。 Objective To optimize the condition for fermentation of recombinant E. coli with fusion gene of SUMO and human fibroblast growth factor-2l (SUMO-rhFGF-21) as well as the procedure for purification of target protein. Methods The temperature and time for induction as well as concentration of inducer of recombinant E. coil was optimized. The recombinant E. coli was ferment- ed under the optimal condition, and the lysate of bactefa was purified by ion exchange, nickel ion affinity and molecular sieve chromatography. The purified target protein was determined for purity by SDS-PAGE and HPLC. Results The optimal temperature and time for induction of recombinant E. coil were 37℃ and 4 h respectively, while the optimal concentration of IPTG as an inducer was 0. 5 mmol/L. The expression level of target protein reached a peak value of 20. 5% under the optimal condition. The yield of bacteria after fermentation reached 66 g/L, and the expression level of target protein was 20. 2%. After purification, the purity of target protein was more than 96%. Conclusion The procedure for expression and purification of rhFGF-21 was optimized, which laid a foundation of developing rhFGF-21 as a novel drug.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第11期1113-1116,共4页 Chinese Journal of Biologicals
基金 吉林省科技厅资助项目(20080712) 长春净月开发区资助项目(2008B003)
关键词 重组人成纤维细胞生长因子-21 SUMO 融合表达 纯化 Recombinant human fibroblast growth factor-21(rhFGF-21) SUMO Fusion expression Purification
  • 相关文献

参考文献9

  • 1Kharitonenkov A, Shanafeh AB. Fibrobias/ growth factor-21 as a therapeutic agent tot metabolic diseases. Bio Drugs, 2008, 22 ( I ): 37-44.
  • 2Kharitonenkov A, Shiyanova TI,, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest, 2005, 115(6 ): 1627-1635.
  • 3Kharitonenkov A, Wroblewski V J, Koester A, et al. The metabolie state of diabetic monkeys is regulated by fibroblast growth factor- 21. Endocrinology, 2007, 148 (2): 774-781.
  • 4Wente W, Efanov AM, Brenner M, et al. Fibroblast growth factor- 21 improves panereatie β-cell function and survival by activation of extraeellular signal-regulated kinase 1 /2 and Akt signaling pathways. American Diabetes Association, 2006, 55 (9): 2470-2478.
  • 5Suzuki M, Uehara Y, Motomura-Matsuzaka K, el al. Beta klutho is required for fibroblast growth factor (FGF)21 signaling through FGF receptor (FGFR)Ic and FGFR3c. Mol Endocrinol, 2008, 22 (4): 1006-1014.
  • 6Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochem et Biophys Acta, 2000, 1492 ( 1 ): 203-206.
  • 7Johnson ES. Protein modification by SUMO. Annual Rev Biochem, 2004, 73(5 ): 355-382.
  • 8Su Z, Huang Y, Zhou Q, et al. High-level expression and purification of human epidermal growth factor with SUMO fusion in Escheriehia coli. Protein Pept Lett, 2006, 13 (8): 785-792.
  • 9陈兴华,李校堃,苏志坚,苏烨,冯娅,肖业臣,孟绢,王艳萍,黄亚东.SUMO蛋白酶活性片段的表达、纯化及活性测定[J].中国生物工程杂志,2007,27(3):34-41. 被引量:12

二级参考文献15

  • 1Butt T R,Edavettal S C,Hall J P,et al.SUMO fusion technology for difficult-to-express proteins.Protein Expression and Purification,2005,43 (1):1 ~ 9
  • 2Muller S,Hoege C,Pyrowolakis G,et al.Sumo,ubiquitin's mysterious cousin.Nature Reviews Molecular Cell Biology,2001,2(3):202 ~210
  • 3Dohmen R J.SUMO protein modification.Biochimica Et Biophysica Acta-Molecular Cell Research,2004,1695 (1-3):113 ~131
  • 4Mossessova E,Lima C D.Ulp1 -SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.Molecular Cell,2000,5(5):865 ~876
  • 5Li S J,Hochstrasser M.The Ulp1 SUMO isopeptidase:distinct domains required for viability,nuclear envelope localization,and substrate specificity.Journal of Cell Biology,2003,160(7):1069 ~ 1081
  • 6Panse V G,Kuster B,Geratberger T,et al.Unconventional tethering of Ulp1 to the transport channel of the nuclear pore complex by karyopherins.Nature Cell Biology,2003,5 (1):21 ~27
  • 7Hang J,Dasso M.Association of the human SUMO-1 protease SENP2 with the nuclear pore.Journal of Biological Chemistry,2002,277(22):19961 ~ 19966
  • 8Li S J,Hochstrasser M.A new protease required for cell-cycle progression in yeast.Nature,1999,398 (6724):246 ~ 251
  • 9Schwienhorst I,Johnson E S,Dohmen R J.SUMO conjugation and deconjugation.Molecular and General Genetics,2000,263(5):771 ~786
  • 10Li S J,Hochstrasser M.The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3protein.Molecular and Cellular Biology,2000,20 (7):2367~2377

共引文献11

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部